Novel Multimodality Treatment Sequencing for Extrahepatic (Mid and Distal) Cholangiocarcinoma

Kiran K. Turaga(Yale New Haven Hospital), T. Clark Gamblin(Medical College of Wisconsin), Susan Tsai(The Ohio State University Wexner Medical Center), Lauren Allison Wiebe(Medical College of Wisconsin), Douglas B. Evans(The University of Texas MD Anderson Cancer Center)
Annals of Surgical Oncology
October 11, 2012
10.1245/s10434-012-2648-0
Cited by 12

Related Papers

Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
|HPB|2011|413
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Population-Based Study of Islet Cell Carcinoma
|Annals of Surgical Oncology|2007|338
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281